Cutaneous Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Cohort Study of Clinical Spectrum and Treatment Patterns. (PubMed, Life (Basel)) - Aug 28, 2026 - "To characterize the phenotypic spectrum of cutaneous GVHD, evaluate real-world treatment strategies-with a specific focus on systemic and topical ruxolitinib-and assess adherence to national and international guidelines, we conducted a retrospective observational study of patients undergoing allo-HSCT between 2015 and 2025 who were referred to a dedicated dermato-haematology clinic. Interpretation should also consider that the study period encompassed changes in regulatory approval, reimbursement, and access to targeted therapies. Structured multidisciplinary assessment may support the management of complex cutaneous GVHD, although its effects on treatment decisions and patient outcomes require prospective evaluation."
Journal • Retrospective data • Acute Graft versus Host Disease • Bone Marrow Transplantation • Chronic Graft versus Host Disease • Graft versus Host Disease • Hematological Disorders • Immunology • Transplantation
|
|
Annunziata Nigro; Annunziata Raimondo; Bianca Serio; Carmine Selleri; Mara Corbisieri; Serena Lembo; Valentina Giudice
|